MAXHEALTH · Health Care · 2026-08-07

Max Healthcare Institute Ltd

3.8WatchWeak -0.2Stage 2 · wk 3In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹1,070
-0.22% today
₹1,04,140 Cr · Large cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Visit company website →
P/E (TTM)
67.5
Forward 40.8
Earnings Growth (YoY)
+7.3%
Revenue +12.2%
ROE
+14.3%
Profit margin +17.2%
Dividend Yield
0.15%
P/B 9.7
vs 52W High
-16.0%
₹931.6 lo₹1,273.9 hi
16.0% below 52W high — deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 3
1w13w26w
Week 3 — fresh breakout, verify structure
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
1.1%
200 DMA: ₹1,057.9 · sloping down
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.50x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -1.3% vs MA50 +2.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
This stock ranks #70 of 79 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Hospitals & Diagnostic Centres
↑ Building
Stage 2%
59.3%
20d Δ
+7.4pp
1M return
+1.2%
3M return
+9.0%
Industry Stage-2 % · last 20 days
Ranks #16 of 16 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-15 → 2026-08-07
S2 15w
S2 27w
S2 15w
S2 22w
S2 21w
S4 30w
2023-05-152026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 15w → S3 9w → S2 27w → S3 3w → S2 15w → S3 1w → S2 22w → S3 7w → S2 21w → S3 10w → S4 30w → S1 5w → S2 2w current
Total tracked: 168 weeks across 13 stage runs.
1M
-2.8%
3M
+5.7%
6M
+11.7%
YTD
+0.6%
1Y
-15.4%
Scan Membership
Breakout Watch
Latest: 2026-07-24
4 appearances in last 60 days. First seen: 2024-06-03.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S2
Wk 3 · Vol —x
2026-08-06S2
Wk 2 · Vol —x
2026-08-05S2
Wk 2 · Vol —x
2026-08-04S2
Wk 2 · Vol —x
2026-08-03S2
Wk 2 · Vol —x
2026-07-31S2
Wk 2 · Vol —x
2026-07-30S2
Wk 1 · Vol —x
2026-07-29S2
Wk 1 · Vol —x
2026-07-28S2
Wk 1 · Vol —x
2026-07-27S2
Wk 1 · Vol —x
2026-07-24S21→2
Wk 1 · Vol —x
2026-07-23S1
Wk 5 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹1,071.7
200 DMA
₹1,057.9
52W High
₹1,273.9
52W Low
₹931.6
5D Low
₹1,070
Resistance levels (recent highs)
20d High
₹1,124.8
60d High
₹1,153.4
120d High
₹1,153.4
250d High
₹1,273.9
Next resistance
+5.1%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.